Long Beach-based Obagi Medical Products, a developer of aesthetic medicine products, said Thursday that it has named Mark T. Taylor as its Senior Vice President, Corporate Development and Investor Relations. Taylor joins the firm from Roth Capital Partners, where he had served in institutional sales, investment banking, and equity research. Taylor also had previously served at ICN Pharmaceuticals, Watson Pharmaceuticals, and MP Biomedicals.
Top NewsFriday, August 17, 2012
Obagi Medical Products Names VP